Actively Recruiting
Prevention of NAFLD and CVD Through Lifestyle Intervention
Led by Pontificia Universidad Catolica de Chile ยท Updated on 2024-11-19
300
Participants Needed
1
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
CONDITIONS
Official Title
Prevention of NAFLD and CVD Through Lifestyle Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 45 to 60 years
- With or without gallstone disease
- With varying degrees of NAFLD, excluding very severe cases
You will not qualify if you...
- Any significant health condition or physical limitation preventing resistance exercise
- Use of medications that affect muscle mass, such as corticosteroids
- History of hepatitis B or C infection
- Use of liver-toxic medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centro MAUCO+
Molina, Maule Region, Chile
Actively Recruiting
Research Team
L
Laura A Huidobro, PhD
CONTACT
C
Catterina Ferreccio, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here